Malaysian Glove Makers Rode An Oil Price Spike To Fatter Margins Now Prices Are Coming Back Down

Kenanga Research is now saying glove prices are set to ease over the coming months after peaking back in May. Nitrile glove prices are expected to slide from around $25 per 1,000 pieces down to somewhere between $20 and $23 as things move into the third quarter. That sounds like a small, boring number shift. It's actually the tail end of a pretty interesting squeeze that just played out across the whole industry.

How oil prices ended up moving glove prices

Here's the chain: nitrile, the main raw material used in a huge chunk of medical and industrial gloves, is petroleum-based. So when oil prices spike, nitrile costs go up right along with it. And that's exactly what happened: geopolitical tensions in the Middle East pushed oil prices up, and nitrile input costs jumped more than 50% during the second quarter of this financial year.

That's a genuinely brutal cost increase to absorb. Kenanga actually ran the math on what that would've meant if glove makers had just eaten the cost themselves: a 50% spike in raw material costs, with zero price pass-through to customers, would've knocked about 20% off the bottom line. That's the kind of hit that turns a decent quarter into a rough one fast.

Why glove makers actually came out ahead anyway

Instead of quietly absorbing that cost, glove makers did the obvious thing: they raised prices. ASPs climbed to somewhere between $26 and $29 per 1,000 pieces, which was enough to not just cover the higher raw material costs, but actually expand margins in the process.

That's why Kenanga's now saying second-quarter earnings for glove makers should actually come in stronger than the first quarter, building on gradual margin improvements that were already showing up earlier in the year. Weirdly, the oil price spike ended up being good for glove makers' profitability, at least temporarily, because they were able to raise prices faster and further than their actual cost increase required.

But that pricing power is already fading.

Now that raw material costs are cooling off, that pricing advantage is starting to unwind too. Nitrile ASPs peaked in May and are already trending down, expected to settle into that $20-23 range by Q3.

There's an interesting buyer behavior shift tied to this too. Kenanga noted that some customers are now choosing to wait, since they can see prices coming down and don't want to lock in at the higher rate. Meanwhile, customers who'd held off buying during the price surge earlier in the year are now stepping back in to place orders, since the numbers look more reasonable again. So you've got two different groups of buyers essentially canceling each other out some waiting, some finally jumping in which should help smooth the transition rather than causing a sudden demand cliff.

Kossan's the one company Kenanga's actually excited about

Out of the major Malaysian glove makers, Kenanga specifically singled out Kossan Rubber Industries as its top pick, and the reasoning comes down to product mix rather than just riding the general glove market.

Kossan's been pivoting toward specialty and cleanroom gloves instead of leaning purely on generic medical gloves, and the economics there are genuinely better. Specialty gloves sell for 60-80% more than standard medical gloves. Cleanroom gloves go even further commanding roughly three times the price premium.

What makes the cleanroom segment particularly attractive isn't just the higher price tag though it's the customer stickiness. Cleanroom applications are mission-critical, meaning the environments where these gloves get used (semiconductor manufacturing, pharma production, that kind of precision work) can't really afford to gamble on switching suppliers to save a bit of money. The cost of something going wrong outweighs any savings from shopping around, which gives Kossan a genuinely durable customer base rather than one constantly shopping for the cheapest option.

Kossan's leaning into that hard expanding cleanroom glove capacity from its current 300-400 million pieces a year all the way up to 800 million pieces by financial year 2027. That's roughly doubling capacity in a segment with meaningfully better margins and stickier customers than the standard glove business.

Not everyone's getting the same treatment

While Kossan got the vote of confidence, Kenanga actually downgraded its overall rating on the glove sector from "overweight" to "neutral," specifically pointing to how Hartalega and Top Glove have performed in the market. So this isn't a blanket "buy glove stocks" call; it's much more selective, favoring companies like Kossan that are actively shifting toward higher-margin, stickier segments of the business rather than staying purely in the commodity glove space where pricing power comes and goes with oil prices and raw material costs.

This whole story is a neat little snapshot of how connected global commodity markets actually are. A conflict thousands of miles away pushes up oil prices, oil prices push up petrochemical costs, petrochemical costs push up nitrile prices, and suddenly Malaysian glove manufacturers are adjusting their pricing strategy and quarterly earnings guidance because of it. And now that the input cost pressure is easing, the whole cycle's starting to unwind in the other direction, prices coming down, margins normalizing, and the companies best positioned to weather that shift being the ones that diversified into higher-value products instead of just riding the commodity price swings.